Bristol-Myers Squibb Belgium

• A01 - Preparados estomatológicos
• FUNGIZONE lozenge 10 mg
• KENACORT A oromucosal paste 1 mg/g
• A07 - Antidiarreicos, antiinfecciosos y antiinflamatorios intestinales
• FUNGIZONE oral suspension 10%
• FUNGIZONE tablet 100 mg
• A10 - Antidiabéticos
• ONGLYZA film-coated tablet 5 mg
• B01 - Agentes antitrombóticos
• ISCOVER film-coated tablet 300 mg
• ISCOVER film-coated tablet 75 mg
• C01 - Terapia cardíaca
• PRONESTYL solution for injection 1 g/10 ml
• PRONESTYL tablet 250 mg
• C07 - Betabloqueantes
• SOTACOR solution for infusion 40 mg/4 ml
• SOTACOR tablet 160 mg
• SOTACOR tablet 80 mg
• C09 - Agentes activos sobre el sistema renina-angiotensina
• ACEPLUS tablet 50 mg+25 mg
• APROVEL tablet 150 mg
• CAPOTEN tablet 12.5 mg
• CAPOTEN tablet 25 mg
• CAPOTEN tablet 50 mg
• CAPOZIDE tablet 50 mg+25 mg
• COAPROVEL film-coated tablet 300 mg+12.5 mg
• DIURACE tablet 20 mg+12.5 mg
• KARVEA film-coated tablet 150 mg
• KARVEA film-coated tablet 300 mg
• KARVEA film-coated tablet 75 mg
• KARVEA tablet 150 mg
• KARVEA tablet 300 mg
• KARVEA tablet 75 mg
• KARVEZIDE film-coated tablet 150 mg+12.5 mg
• KARVEZIDE film-coated tablet 300 mg+12.5 mg
• KARVEZIDE film-coated tablet 300 mg+25 mg
• KARVEZIDE tablet 150 mg+12.5 mg
• KARVEZIDE tablet 300 mg+12.5 mg
• NEWACE tablet 10 mg
• NEWACE tablet 20 mg
• C10 - Agentes modificadores de los lípidos
• QUESTRAN A powder for oral suspension 4 g
• QUESTRAN powder for oral suspension 4 g
• SELEKTINE tablet 10 mg
• SELEKTINE tablet 20 mg
• SELEKTINE tablet 40 mg
• D07 - Preparados dermatológicos con corticosteroides
• KENALOG TINCTUUR cutaneous solution 0.2%+2%
• D11 - Otros preparados dermatológicos
• VANIQA cream 11.5%
• H02 - Corticosteroides para uso sistémico
• FLORINEF tablet 0.1 mg
• KENACORT A suspension for injection 40 mg/1 ml
• KENACORT A suspension for injection 50 mg/5 ml
• KENACORT tablet 4 mg
• J01 - Antibacterianos para uso sistémico
• AMUKIN solution for injection 100 mg/2 ml
• AMUKIN solution for injection 500 mg/2 ml
• AZACTAM powder for solution for injection 1 g
• AZACTAM powder for solution for injection 2 g
• CEFACIDAL powder and solvent for solution for injection 1 g+5 ml
• PENTREXYL powder for solution for injection 1 g
• PENTREXYL powder for solution for injection 250 mg
• PENTREXYL powder for solution for injection 500 mg
• VELOSEF capsule, hard 500 mg
• VELOSEF powder for oral suspension 250 mg/5 ml
• J02 - Antimicóticos de uso sistémico
• FUNGIZONE powder for solution for infusion 50 mg
• J05 - Antivirales de uso sistémico
• ATRIPLA film-coated tablet 200 mg+245 mg+600 mg
• BARACLUDE film-coated tablet 0.5 mg
• BARACLUDE film-coated tablet 1 mg
• BARACLUDE oral solution 0.05 mg/ml
• REYATAZ capsule, hard 100 mg
• REYATAZ capsule, hard 150 mg
• REYATAZ capsule, hard 200 mg
• REYATAZ capsule, hard 300 mg
• REYATAZ powder for oral solution 50 mg/1.5 g
• SUSTIVA capsule, hard 100 mg
• SUSTIVA capsule, hard 200 mg
• SUSTIVA capsule, hard 50 mg
• SUSTIVA film-coated tablet 300 mg
• SUSTIVA film-coated tablet 600 mg
• SUSTIVA oral solution 30 mg/ml
• VIDEX EC gastro-resistant capsule, hard 125 mg
• VIDEX EC gastro-resistant capsule, hard 200 mg
• VIDEX EC gastro-resistant capsule, hard 250 mg
• VIDEX EC gastro-resistant capsule, hard 400 mg
• VIDEX powder for oral solution 2 g
• ZERIT capsule, hard 15 mg
• ZERIT capsule, hard 20 mg
• ZERIT capsule, hard 30 mg
• ZERIT capsule, hard 40 mg
• ZERIT powder for oral suspension 1 mg/ml
• ZERIT prolonged-release capsule, hard 100 mg
• ZERIT prolonged-release capsule, hard 37.5 mg
• ZERIT prolonged-release capsule, hard 50 mg
• ZERIT prolonged-release capsule, hard 75 mg
• L01 - Antineoplásicos
• HYDREA capsule, hard 500 mg
• PARAPLATIN concentrate for solution for infusion 150 mg/15 ml
• PLATINOL concentrate for solution for infusion 2.5 mg/50 ml
• PLATINOL powder for solution for infusion 10 mg
• PLATINOL powder for solution for infusion 50 mg
• SPRYCEL film-coated tablet 20 mg
• SPRYCEL film-coated tablet 50 mg
• SPRYCEL film-coated tablet 70 mg
• TAXOL concentrate for solution for infusion 100 mg/16.7 ml
• TAXOL concentrate for solution for infusion 30 mg/5 ml
• TAXOL concentrate for solution for infusion 300 mg/50 ml
• UFT capsule, hard 100 mg+224 mg
• VEPESID capsule, soft 100 mg
• VEPESID capsule, soft 50 mg
• VEPESID concentrate for solution for infusion 100 mg/5 ml
• VUMON solution for infusion 50 mg/5 ml
• L02 - Terapia endocrina
• MEGACE tablet 160 mg
• MEGACE tablet 40 mg
• L04 - Inmunosupresores
• ORENCIA powder for solution for infusion 250 mg
• N02 - Analgésicos
• NUBAIN solution for injection 10 mg/1 ml
• PERFALGAN solution for infusion 1 g/100 ml
• N05 - Psicolépticos
• ABILIFY oral solution 1 mg/ml
• ABILIFY orodispersible tablet 10 mg
• ABILIFY orodispersible tablet 15 mg
• ABILIFY orodispersible tablet 30 mg
• ABILIFY orodispersible tablet 5 mg
• ANATENSOL coated tablet 5 mg
• ANATENSOL solution for injection 100 mg/ml
• ANATENSOL solution for injection 25 mg/ml
• BUSPAR tablet 10 mg
• SIQUIL tablet 10 mg
• SIQUIL tablet 25 mg
• N06 - Psicoanalépticos
• DUTONIN tablet 100 mg
• DUTONIN tablet 200 mg
• N07 - Otros fármacos activos sobre el sistema nervioso
• NALOREX film-coated tablet 50 mg
• REVIA film-coated tablet 50 mg
• R05 - Preparados para la tos y el resfriado
• MUCOMYST nebuliser solution 20%
• V03 - Todos los demás preparados terapéuticos
• NARCAN NEONATAAL solution for injection 0.04 mg/2 ml
• NARCAN solution for injection 0.4 mg/1 ml
• V04 - Agentes diagnósticos
• NATRIUMJODIDE (I 123) capsule, hard 3.7 Mbq
• NATRIUMJODIDE (I 123) solution for infusion 3.7 Mbq/ml
• V08 - Medios de contraste
• LUMINITY solution for injection 225 µl/1.5 ml